Preparing for introduction of a dengue vaccine: Recommendations from the 1st Dengue v2V Asia-Pacific Meeting

Highlights ► Dengue vaccines will be available in the near future. ► Preparation for their introduction needs to start now. ► Recommendations for the rapid introduction of a dengue vaccine are presented. ► These are documenting of costs, ensuring quality surveillance/diagnostics systems. ► Also deve...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2011-11, Vol.29 (51), p.9417-9422
Main Authors: Lam, Sai Kit, Burke, Donald, Capeding, Maria Rosario, Chong, Chee Keong, Coudeville, Laurent, Farrar, Jeremy, Gubler, Duane, Hadinegoro, Sri Rezeki, Hanna, Jeffrey, Lang, Jean, Lee, Han Lim, Leo, Yee Sin, Luong, Chan Quang, Mahoney, Richard, Mcbride, John, Mendez-Galvan, Jorge, Ng, Lee Ching, Nimmannitya, Suchitra, Ooi, Eng Eong, Shepard, Donald, Smit, Jaco, Teyssou, Rémy, Thomas, Laurent, Torresi, Joseph, Vasconcelos, Pedro, Wirawan, Dewa Nyoman, Yoksan, Sutee
Format: Article
Language:English
Subjects:
Allergy and Immunology
Asia
Asia-Pacific
Congresses as Topic
Costs
Dengue
Dengue - drug therapy
Dengue - prevention & control
Dengue fever
Dengue Vaccines - administration & dosage
Dengue virus
Dengue Virus - immunology
diagnostic techniques
experts
funding
Global health
Health Planning Guidelines
Humans
Immunization
Immunization Programs - economics
Meetings
monitoring
Public Health
Reporting requirements
Studies
subtropics
Vaccination
vaccine development
Vaccine introduction
Vaccines
Vector-borne diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights ► Dengue vaccines will be available in the near future. ► Preparation for their introduction needs to start now. ► Recommendations for the rapid introduction of a dengue vaccine are presented. ► These are documenting of costs, ensuring quality surveillance/diagnostics systems. ► Also development of transferable tools/programmes and securing sustainable funding.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2011.08.047